caused by SOX10 mutations) (8) . The causative genes for WS2B and WS2C remain to be identified.
The mutations of aforementioned genes can only explain the etiology of 50% of WS2 cases (4).
To date, several mutations have been identified related to WS in many populations. However, the Iranian population has been rarely investigated, with few reports being published on WS2. In fact, the only published report deals with a large WS2 kindred with unique spectrum of ocular findings and a novel MITF pathogenic variant (9) . In this study, we performed a comprehensive clinical and genetic study on a set of Iranian WS2 cases, which led to better delineating phenotypic features, and revealed two pathogenic variants in MITF and
SOX10.

Materials and methods
Participants
In this case series study, patients were enrolled from the ENT and the Head and Neck Surgery 
Results
Clinical description
Totally, 31 WS2 patients, including 22 men and 9 women from 14 families, and their healthy family members were enrolled. The study population comprised 5 familial and 9 sporadic cases ranging from 12 months to 77 years old.
HI was the most common clinical feature observed in our WS2 cases (67%, 21/31), followed by heterochromia iridis (45%, 14/31). HI was mostly observed as bilateral non-progressive severe to profound sensorineural; however, a case of WS2
with progressive SNHI was also observed.
Distribution of WS2 clinical features among the WS2 study population is shown in Figure 1 . As depicted in the figure, anosmia was the least frequent feature observed in only one patient. 
GCTTCTGACACTACTGTGTT F HBB CACCAACTTCATCCACGTT R HBB Fig. 1 . Distribution of WS2 associated phenotypes in the study population. Hearing impairment is the most frequent, and anosmia is the least frequent feature among Iranian WS2 patients. as the most prevalent findings (12, 13); however, there might be slight differences among ethnic groups (13) . Interestingly, the distribution of WS2 in our studied population followed the same pattern where HI and heterochromia iridis were the most prevalent findings among Iranian WS2 patients (frequencies of 67% and 45%, respectively).
There is only one MITF mutation described in Iranian WS2 cases so far (9) 
